Jeffrey Langsam stock trades
Chief Clinical Officer of Starling Oncology
No open-market buys or sales reported in the last 12 months. Their newest Form 4, for Mar 27: stock award (70,270 STLN shares).
Where Jeffrey Langsam files
Each title as their newest Form 4 there gives it, and the open-market trades there in the last 12 months. Open any stock for its score. Pro members see every stock ranked.
| Company | Trades | Quality Score |
|---|---|---|
| 0 |
Jeffrey Langsam's trades, as filed
None on the open market in the last 12 months.
1 other filing on record (stock award). Pro members see every filing and the shares Jeffrey Langsam holds.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.